LSPN LIVE 2021: an ‘unmissable opportunity’


Muireann Bolger

LSPN LIVE 2021: an ‘unmissable opportunity’

Poptika /

Over the past year, the life sciences sector has proved to be of vital importance in the fight against COVID-19. Now more than ever, it is imperative that IP professionals are best positioned to protect and leverage innovation in this fast-paced industry.

LSPN, COVID-19, innovation, life sciences, CJEU, UPC, IP portfolio, patents, antibodies, second medical use